“…Glutamate release or increased activity of EAATs in astrocytes could thus be a relevant mechanism of treatment in diseases involving glutamate-mediated cytotoxicity. On the other hand, glutamate can also promote oligodendrocyte differentiation by activating various glutamate receptors ( Tsitsilashvili et al, 2018 ), and it can also regulate the remyelination process ( Wheeler and Fuss, 2016 ). Thus, variation in astrocyte-dependent release and removal of extracellular glutamate may be essential in oligodendrocyte homeostasis.…”